.png)
.png)
Recognized as one of the top 3 Digital Health companies at CES 2021 and Winner of the AAP Urologic Device Innovation Award for 2021, GOGO Band is pioneering the use of AI predictive analytics and machine learning using biometric data captured from fourth generation wearable sensors to transform the lives of those suffering from chronic health conditions. This novel approach is first being deployed in a non-invasive, non-pharmaceutical, home-based consumer solution for Pediatric Enuresis (PE), more commonly known as bedwetting, which is the #1 chronic health condition in children worldwide. The root cause of PE stems from a maturation delay in the child’s bladder-to-brain neural pathway resulting in the inability of these children to recognize that their bladders need to void. In other words, this bladder voiding signal is “lost” and is never sensed by the child. The GOGO Band System represents a game-changing shift in the treatment of PE combining revolutionary advances in biometric wearable technology, predictive analytics, and machine learning to finally bring the treatment of PE into the 21st Century. The multi-patented GOGO Band System uses fourth generation, biometric wearable sensor technology that can measure, in real-time, the detailed heart rate metrics and other biometric patterns and telemetry of the child. By applying proprietary AI predictive models, an accurate prediction of the accidental bedwetting event is made before it occurs. This enables the system to wake the child before an accidental bedwetting event, keeping them dry and precludes the need for diapers or drugs. By predictively alerting as the bladder voiding signal is actually being sent, the system conditions the child to recognize and respond to their previously “lost” voiding signal faster and deeper than current treatment options. Children who were wetting 6+ nights a week were 93% dry after only 60 days of consistent use of the GOGO Band System. Over a period of time, typically ranging from three to six months, the GOGO Band System will more than double the efficacy over current treatment options available in the market today.
